Jack Tarleton

2.6k total citations
50 papers, 1.9k citations indexed

About

Jack Tarleton is a scholar working on Genetics, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Jack Tarleton has authored 50 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Genetics, 33 papers in Molecular Biology and 18 papers in Cognitive Neuroscience. Recurrent topics in Jack Tarleton's work include Genetics and Neurodevelopmental Disorders (34 papers), Autism Spectrum Disorder Research (18 papers) and Genomic variations and chromosomal abnormalities (16 papers). Jack Tarleton is often cited by papers focused on Genetics and Neurodevelopmental Disorders (34 papers), Autism Spectrum Disorder Research (18 papers) and Genomic variations and chromosomal abnormalities (16 papers). Jack Tarleton collaborates with scholars based in United States, Canada and India. Jack Tarleton's co-authors include Robert A. Saul, Charles E. Schwartz, Ave M. Lachiewicz, P. Goonewardena, Allyn McConkie‐Rosell, Gail A. Spiridigliozzi, Mary C. Phelan, Dominique Heitz, Angela Barnicoat and Étienne Mornet and has published in prestigious journals such as Nucleic Acids Research, Nature Genetics and Journal of Bacteriology.

In The Last Decade

Jack Tarleton

49 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jack Tarleton United States	19	1.5k	1.0k	749	188	162	50	1.9k
Anne Moncla France	24	1.3k 0.9×	1.1k 1.0×	343 0.5×	89 0.5×	185 1.1×	38	1.9k
Nancy J. Carpenter United States	24	1.2k 0.8×	1.0k 1.0×	325 0.4×	184 1.0×	292 1.8×	72	2.2k
Angela Barnicoat United Kingdom	19	1.2k 0.8×	947 0.9×	469 0.6×	168 0.9×	184 1.1×	43	1.6k
Laia Rodríguez‐Revenga Spain	23	1.4k 0.9×	873 0.9×	455 0.6×	128 0.7×	356 2.2×	87	1.9k
Derek P.A. Kuhl United States	6	1.5k 1.0×	1.1k 1.1×	732 1.0×	333 1.8×	59 0.4×	6	1.8k
Amanda Collins United Kingdom	18	944 0.6×	824 0.8×	209 0.3×	130 0.7×	117 0.7×	36	1.6k
Maria Antonietta Mencarelli Italy	26	1.2k 0.8×	982 1.0×	354 0.5×	81 0.4×	105 0.6×	65	1.9k
C. T. R. M. Schrander‐Stumpel Netherlands	24	1.4k 0.9×	671 0.7×	209 0.3×	160 0.9×	411 2.5×	86	2.1k
Dominique Heitz France	15	2.4k 1.6×	1.6k 1.6×	1.4k 1.8×	251 1.3×	97 0.6×	23	2.8k
Zohreh Talebizadeh United States	17	1.0k 0.7×	973 1.0×	422 0.6×	75 0.4×	123 0.8×	31	1.7k

Countries citing papers authored by Jack Tarleton

Since Specialization

Citations

This map shows the geographic impact of Jack Tarleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Tarleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Tarleton more than expected).

Fields of papers citing papers by Jack Tarleton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Tarleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Tarleton. The network helps show where Jack Tarleton may publish in the future.

Co-authorship network of co-authors of Jack Tarleton

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Tarleton. A scholar is included among the top collaborators of Jack Tarleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Tarleton. Jack Tarleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Richardson, Randal, Jack Tarleton, Thomas D. Bird, & Sídney M. Gospe. (2013). Truncating CLCN1 mutations in myotonia congenita: Variable patterns of inheritance. Muscle & Nerve. 49(4). 593–600. 10 indexed citations

Kalman, Lisa V., Jack Tarleton, Madhuri Hegde, et al.. (2013). Development of a Genomic DNA Reference Material Panel for Myotonic Dystrophy Type 1 (DM1) Genetic Testing. Journal of Molecular Diagnostics. 15(4). 518–525. 14 indexed citations

Kalman, Lisa V., Jay Leonard, Norman P. Gerry, et al.. (2011). Quality Assurance for Duchenne and Becker Muscular Dystrophy Genetic Testing. Journal of Molecular Diagnostics. 13(2). 167–174. 18 indexed citations

Pratt, Victoria M., Michele Caggana, Arlene Buller, et al.. (2009). Development of Genomic Reference Materials for Cystic Fibrosis Genetic Testing. Journal of Molecular Diagnostics. 11(3). 186–193. 27 indexed citations

Tarleton, Jack, et al.. (2008). Extraocular muscle hypertrophy in myotonia congenita. Journal of American Association for Pediatric Ophthalmology and Strabismus. 12(3). 294–296. 8 indexed citations

Tarleton, Jack, et al.. (2008). Recessive CLCN1 mutation presenting as thomsen disease. Muscle & Nerve. 38(5). 1515–1517. 3 indexed citations

Chalifoux, Mathieu, P. N. Howard‐Peebles, A Maddalena, et al.. (1997). Natural history of cognitive and adaptive behavior in young fragile X males and females: A 6-year prospective multicenter study. The American Journal of Human Genetics. 61(4).

Curry, Cynthia J., Roger E. Stevenson, David J. Aughton, et al.. (1997). Evaluation of mental retardation: Recommendations of a consensus conference. American Journal of Medical Genetics. 72(4). 468–477. 266 indexed citations

McConkie‐Rosell, Allyn, Gail A. Spiridigliozzi, Timothy Iafolla, Jack Tarleton, & Ave M. Lachiewicz. (1997). Carrier testing in the fragile X syndrome: Attitudes and opinions of obligate carriers. American Journal of Medical Genetics. 68(1). 62–69. 48 indexed citations

10.

Fisch, Gene S., Richard J. Simensen, Jack Tarleton, et al.. (1996). Longitudinal study of cognitive abilities and adaptive behavior levels in fragile X males: A prospective multicenter analysis. American Journal of Medical Genetics. 64(2). 356–361. 67 indexed citations

11.

Fisch, Gene S., Nancy J. Carpenter, Patricia N. Howard‐Peebles, et al.. (1996). Lack of association between mutation size and cognitive/behavior deficits in fragile X males: A brief report. American Journal of Medical Genetics. 64(2). 362–364. 8 indexed citations

12.

Lachiewicz, Ave M., Gail A. Spiridigliozzi, Allyn McConkie‐Rosell, et al.. (1996). A fragile X male with a broad smear on southern blot analysis representing 100–500 CGG repeats and no methylation at theEagI site of the FMR-1 gene. American Journal of Medical Genetics. 64(2). 278–282. 18 indexed citations

13.

Wenger, Sharon L., et al.. (1996). Inability to induce fragile sites at CTG repeats in congenital myotonic dystrophy. American Journal of Medical Genetics. 66(1). 60–63. 14 indexed citations

14.

Michaelis, Ron C., Steven A. Skinner, Richard J. Simensen, et al.. (1995). Deletion involving D15S113 in a mother and son without Angelman syndrome: Refinement of the Angelman syndrome critical deletion region. American Journal of Medical Genetics. 55(1). 120–126. 9 indexed citations

15.

Zhao, Jian, Patricia Gordon, R. Sid Wilroy, et al.. (1995). Characterization of an unbalanced de novo rearrangement by microsatellite polymorphism typing and by fluorescent in situ hybridization. American Journal of Medical Genetics. 56(4). 398–402. 9 indexed citations

16.

Cao, Jie, et al.. (1994). A simple fragile X PCR assay with 7-deazaguanine-substituted DNA visualized by ethidium bromide. Molecular and Cellular Probes. 8(2). 177–180. 8 indexed citations

17.

McConkie‐Rosell, Allyn, Ave M. Lachiewicz, Gail A. Spiridigliozzi, et al.. (1993). Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome.. PubMed. 53(4). 800–9. 138 indexed citations

18.

Tarleton, Jack, et al.. (1993). An Extensive de novo deletion removing FMR1 in a patient with mental retardation and the fragile X syndrome phenotype. Human Molecular Genetics. 2(11). 1973–1974. 58 indexed citations

19.

Richards, Robert I., Katherine Holman, K. Friend, et al.. (1992). Evidence of founder chromosomes in fragile X syndrome. Nature Genetics. 1(4). 257–260. 152 indexed citations

20.

Tarleton, Jack & Charles E. Schwartz. (1991). Using the polymerase chain reaction to maintain DNA probe inventories in clinical and diagnostic laboratories. Clinical Genetics. 39(2). 121–124. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact